Abstract
Osteoporosis is a disease characterized by an inadequate amount and/or faulty structure of bone, resulting in fractures from relatively minor trauma. Although, osteoporotic fractures are most commonly observed among the elderly, the pathogenesis of osteoporosis starts early in life and involves the interaction of multiple environmental and genetic factors (1,2). Considerable past research has centered on the influence of reproductive, nutritional and/or lifestyle factors on the development of osteoporosis. With the advent of new molecular genetic approaches, the focus of research has recently shifted towards genetic factors. Genetic epidemiological studies provide convincing descriptive data demonstrating population and ethnic differences. In addition, studies of familial aggregation, familial transmission patterns, and comparisons of twin concordance rates consistently identify a significant portion of the vulnerability to develop osteoporosis as being inherited. Almost certainly, the development of osteoporosis will be found to involve a complex interplay between both genetic and environmental factors.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ferrari S, Rizzoli R, Bonjour J-P. Heritable and nutritional influences on bone mineral mass. Aging Clin Exp 1998; 10: 205–213.
Eisman JA. Genetics of osteoporosis. Endocr Rev 1999; 20: 788–804.
Lutz J. Bone mineral, serum calcium, and dietary intakes of mother/daughter pairs. Am J Clin Nutr 1986; 44: 99–106.
Sowers MR, Boehnke M, Jannausch ML, Crutchfield M, Corton G, Burns TL. Familiality and partitioning the variability of femoral bone mineral density in women of child-bearing age. Calcif Tissue Int 1992; 50 (2): 110–114.
Krall EA, Dawson-Hughes B. Heritable and life-style determinants of bone mineral density. J Bone Miner Res 1993; 8: 1–9.
Jouanny P, Guillemin F, Kuntz C, Jeandel C, Pourel J. Environmental and genetic factors affecting bone mass: similarity of bone density among members of healthy families. Arth Rheum 1995; 38: 61–67.
Evans RA, Marel GM, Lancaster EK, Kos S, Evans M. Bone mass is low in relatives of osteoporotic patients. Ann Intern Med 1988; 109: 870–873.
Seeman E, Hopper JL, Bach LA, Cooper ME, Parkinson E, McKay J, et al. Reduced bone mass in daughters of women with osteoporosis. N Engl J Med 1989; 320: 554–558.
Seeman E, Tsalamandris C, Formica C, Hopper JL, McKay J. Reduced femoral neck bone density in the daughters of women with hip fractures: the role of low peak bone density in the pathogenesis of osteoporosis. J Bone Miner Res 1994; 9: 739–743.
Danielson ME, Cauley JA, Baker CE, Newman AB, Dorman JS, Towers JD, et al. Familial resemblance of bone mineral density (BMD) and calcaneal ultrasound attenuation: the BMD in mothers and daughters study. J Bone Miner Res 1999; 14 (1): 102–110.
Rubin LA, Hawker GA, Peltekova VD, Fielding LJ, Ridout R, Cole DEC. Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort. J Bone Miner Res 1999; 14: 633–643.
Soroka SB, Barrett-Connor E, Edelstein SL, Kritz-Siverstein D. Family history of osteoporosis and bone mineral density at the axial skeleton: The Rancho Bernardo study. J Bone Miner Res 1994; 9: 761–769.
Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, et al. Risk factors for hip fractures in white women. N Engl J Med 1995; 332: 767–773.
Lonzer MD, Imrie R, Rogers D, Worley D, Licata A, Secic M. Effects of heredity, age, weight, puberty, activity, and calcium intake on bone mineral density in children. Clin Pediatr 1996, 35: 185–189.
Ferrari S, Rizzoli R, Slosman D, Bonjour J-P. Familial resemblance for bone mineral mass is expressed before puberty. J Clin Endocrinol Metab 1998; 83: 358–361.
Spotila LD, Caminis J, Devoto M, Shimoya K, Sereda L, Ott J, et al. Osteopenia in 37 members of seven families: analysis based on a model of dominant inheritance. Mol Med 1996; 2: 313–324.
Livshits G, Pavlovsky O, Kobyliansky E. Population biology of human aging: segregation analysis of bone age characteristics. Hum Biol 1996, 68: 539–554.
Livshits G, Karaski D, Pavlovsky O, Kobyliansky E. Segregation analysis reveals a major gene effect in compact and cancellous bone mineral density in 2 populations. Hum Biol 1999; 71: 155–172.
Cardon LR, Garner C, Bennett ST, Mackay IJ, Edwards RM, Cornsih J, et al. Evidence for a major gene for bone mineral density in idiopathic osteoporotic families. J Bone Miner Res 2000; 15: 1132–1137.
Smith DM, Nance WE, Kang KW, Christian JC, Johnston CC. Genetic factors in determining bone mass. J Clin Invest 1973; 52: 2800–2808.
Dequeker J, Nys J, Verstracten A, Geusens P, Gevers G. Genetic determinants of bone mineral content at the spine and radius: a twin study. Bone 1987; 8: 207–209.
Moller M, Horsman A, Harvald B, Hauge M, Henningsen K, Nordin BE. Metacarpal morphometry in monozygotic dizygotic elderly twins. Calcif Tiss Int 1978; 25: 197–201.
Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S. Genetic determinants of bone mass in adults: a twin study. J Clin Invest 1987; 80: 706–710.
Slemenda CW, Christian JC, Williams CJ, Norton JA, Johnston CC. Genetic determinants of bone mass in adult women: A reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res 1991; 6: 561–567.
Arden NK, Baker J, Hogg C, Baan K, Spector TD. The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins. J Bone Miner Res 1996; 11: 530–534.
Christian JC, Yu PL, Slemenda CW, Johnston CC. Heritability of bone mass: a longitudinal study in aging male twins. Am J Hum Genet 1989; 44: 429–433.
Slemenda CW, Christian JC, Reed T, Reister TK, Williams CJ, Johnston CCJ. Long-term bone loss in men: effects of genetic and environmental factors. Ann Intern Med 1992; 117: 286–291.
Kelly PJ, Nguyen T, Hooper J, Pocock N, Sambrook P, Eisman J. Changes in axial bone density with age. J Bone Miner Res 1993; 8: 11–17.
Kannus P, Palvanen M, Kaprio J, Parkkari J, Koskenvuo M. Genetic factors and osteoporotic fracture in elderly people: prospective 25 year follow up of a nationwide cohort of elderly Finnish twins. Br Med J 1999; 319: 1334–1337.
MacGregor A, Sneider H, Spector TD. Genetic factors and osteoporotic fractures in elderly people: twin data support genetic contribution to risk of fracture. Br Med J 2000; 320: 1669.
Kelly PJ, Hopper JL, Macaskill GT, Pocock NA, Sambrook PN, Eisman JA. Genetic factors in bone turnover. J Clin Endocrinol Metab 1991; 72: 808–813.
Tokita A, Kelly PJ, Nguyen TV, Qi JC, Morrison NA, Risteli L, et al. Genetic influences on type I collagen synthesis and degradation: Further evidence for genetic regulation of bone turnover. J Clin Endocrinol Metab 1994; 78 (6): 1461–1466.
Garnero P, Arden NK, Griffiths G, Delmas PD, Spector TD. Genetic influences on bone turnover in postmenopausal twins. J Clin Endocrinol Metab 1996; 81: 140–146.
Livshits G, Yakovenko C, Kobyliansky E. Quantitative genetic analysis of circulating levels of biochemcial markers of bone fromation. Am J Hum Genet 2000; 94: 324–331.
Econs MJ, Speer MC. Genetic studies of complex diseases: let the reader beware. J Bone Miner Res 1996; 11: 1835–1840.
Spielman RS, Ewens WJ. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996; 59: 983–989.
Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994; 265: 2037–2048.
Risch N, Merikangas K. The future of genetic studies of complex human disease. Science 1996; 272: 1516–1517.
Prockop DJ. Genetic trail of osteoporosis: candidate genes versus genome screens? Small families versus large families? J Bone Miner Res 1999; 14: 2000–2001.
Hui SL, Slemenda CW, Johnston CCJ. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 1988; 81: 1804–1809.
Cummings SR, Black DM, Nevitt MC, Browner WS, Cauley JA, Genant HK, et al. Appendicular bone density and age predict hip fracture in women. JAMA 1990; 263: 665–668.
Nguyen T, Sambrook P, Kelly P, Jones G, Lord S, Freund J, Eisman J. Prediction of osteoporotic fractures by postural instability and bone density. Br Med J 1993; 307: 1111–1115.
Lander ES, Botstein D. Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 1989; 121: 185–199.
Dietrich W, Katz H, Lincoln SE, Shin HS, Friedman J, Dracopoli N, et al. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 1992; 131: 423–447.
Dietrich WF, Miller JC, Steen RG, Merchant M, Damron D, Nahf R, et al. A genetic map of the mouse with 4,006 simple sequence length polymorphisms. Nature Genet 1994; 7: 220–245.
Weeks DE, Lathrop GM. Polygenic disease: Methods for mapping complex disease traits. Trends Genet 1995; 11: 513–519.
Schork N, Chakravarti A. A nonmathematical overview of modern gene mapping techniques applied to human diseases. In: Mockrin S, ed. Molecular Genetics and Gene Therapy of Cardiovascular Disease. Marcel Dekker, New York, 1996, pp. 79–109.
Schork NJ. Genetically complex cardiovascular traits: origins, problems, and potential solutions. Hypertension 1997; 29: 145–149.
Schork NJ. Extended multipoint identity-by-descent analysis of human quantitative traits: efficiency, power, and modeling considerations. Am J Hum Genet 1993; 53: 1306–1319.
Schork NJ, Xu X. Sibpairs versus pedigrees: what are the advantages? Diabetes Reviews 1996; 5: 1–7.
Schork NJ, Nath SP, Lindpaintner K, Jacob HJ. Extensions of quantitative trait locus mapping in experimental organisms. Hypertension 1996; 28: 1104–1111.
Kruglyak L, Lander ES. High-resolution genetic mapping of complex traits. Am J Hum Genet 1995; 56: 1212–1223.
Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284–287.
Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, et al. Prediction of bone density from vitamin D receptor alleles. Nature 1997; 387: 106.
Hustmyer FG, Peacock M, Hui S, Johnston CC, Christian J. Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus. J Clin Invest 1994; 94: 2130–2134.
Peacock M, Hustmyer FG, Hui S, Johnston CCJ, Christian JC. Vitamin D receptor genotype and bone mineral density-evidence conflicts on link. Br Med J 1995; 311: 874–875.
Melhus H, Kindmark A, Am’er S, Wil’en B, Lindh E, Ljunghall S. Vitamin D receptor genotypes in osteoporosis. Lancet 1994; 344 (8927): 949–950.
Yamagata Z, Miyamura T, lijima S, Asaka A, Sasaki M, Kato J, et al. Vitamin D receptor gene polymorphism and bone mineral density in healthy Japanese women. Lancet 1994; 344: 1027.
Looney JE, Yoon HK, Fischer M, Farley SM, Farley JR, Wergedal JE, et al. Lack of a high prevalence of the BB vitamin D receptor genotype in severely osteoporotic women. J Clin Endocrinol Metab 1995; 80 (7): 2158–2162.
Spector TM, Keen RW, Arden NK, Morrison NA, Major PJ, Nguyen TV, et al. Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. Br Med J 1995; 310: 1357–1360.
Krall EA, Parry P, Lichter JB, Dawson-Hughes B. Vitamin D receptor alleles and rates of bone loss: influence of years since menopause and calcium intake. J Bone Miner Res 1995; 10: 978–984.
Fleet JC, Harris SS, Wood RJ, Dawson-Hughes B. The Bsm I vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women. J Bone Miner Res 1995; 10.
Riggs BL, Nguyen TV, Melton LJr, Morrison NA, O’Fallon WM, Kelly PJ, et al. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res 1995; 10 (6): 991–996.
Garnero P, Borel O, Sornay-Rend E, Delmas PD. Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal women. J Bone Miner Res 1995; 10: 1283–1288.
Garnero P, Borel O, Sornay Rendu E, Arlot ME, Delmas PD. Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: the OFELY Study. J Bone Miner Res 1996; 11 (6): 827–834.
Harris SS, Eccleshall TR, Gross C, Dawson-Hughes B, Feldman D. The vitamin D receptor start codon polymoprhism (FokI) and bone mineral density in premenopausal American black and white women. J Bone Miner Res 1997; 12: 1043–1048.
Gennari L, Becherini L, Masi L, Mansani R, Gonnelli S, Cepollaro C, et al. Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density. J Clin Endocrinol Metab 1998; 83: 939–944.
Fountas L, Moutsatsou P, Kastanias I, Tamouridis N, Tzanela M, Anapliotou M, et al. The contribution of vitamin D receptor gene polymorphisms in osteoporosis and familial osteoporosis. Osteo Int1999; 10: 392–398.
Cooper GS, Umbach DM. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res 1996; 11: 1841–1849.
Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler M, Pike JW, Shine J, O’Malley BW. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 1988; 85: 3294–3298.
Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 1996; 11 (12): 1850–1855.
Eccleshall TR, Garnero P, Gross C, Delmas PD, Feldman D. Lack of correlation between start codon polymorphism of the vitamin D receptor gene and bone mineral density in premenopausal French women: the OFELY study. J Bone Miner Res 1998; 13: 31–35.
Econs MJ, Koller DL, Considine EL, Takacs I, Christian JC, Connally PM, et al. Association and sib pair linkage analysis studies between BMD and the vitamin D receptor (VDR). Bone 1998; 23: S271.
Prockop DJ, Constantinou CD, Dombrowski KE, Johima Y, Kadler KE, Kuivaniemi H, Tromp G, et al. Type I procollagen: The gene-protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue. Am J Med Genet 1989; 34: 60–67.
Spotila LD, Constantinou CD, Sereda L, Ganguly A, Riggs BL, Prockop DJ. Mutation in a gene for type I procollagen (COL1A2) in a woman with postmenopausal osteoporosis: Evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta. Proc Natl Acad Sci USA 1991; 88: 5423–5427.
Grant SF, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH. Reduced bone density and osteoporosis associated with a polymorphic Spl binding site in the collagen type I alpha 1 gene. Nat Genet 1996; 14 (2): 203–205.
Uitterlinden AG, Burger H, Huang Q, Yue F, McGuigan FEA, Grant SFA, et al. Relation of the alleles of the collagen typelal gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med 1998; 338: 1016–1021.
McGuigan FEA, Reid DM, Ralston SH. Susceptibility to osteoporotic fracture is determined by allelic variation at the Spl site, rather than other polymorphic sites at the COL lA i locus. Osteoporos Int 2000; 11: 338–343.
Langdahl BL, Ralston SH, Grant SFA, Eriksen EF. An Spl binding site polymorphism in the COL 1 A 1 gene predicts osteoporotic fractures in both men and women. J Bone Miner Res 1997;12 (Suppl).
Keen RW, Woodford-Richens KL, Grant SFA, Lanchbury JS, Ralston SH, Spector TD. Type I collagen gene polymorphism is associated with osteoporosis and fracture. J Bone Miner Res 1997; 12 (Suppl): S489.
Garnero P, Borel O, Grant SFA, Ralston SH, Delmas PD. Spl binding site polymorphism in the collagen type I al gene, peak bone mass, postmenopausal bone loss, and bone turnover: the OFELY study. J Bone Miner Res 1997; 12 (Suppl): S490.
Haughton MA, Gunnell AS, Grant SFA, Brown MA, Eisman JA. Linkage studies of the COL 1Al and VDR loci in the control of bone mineral density. Bone 1998; 23: S370.
Hustmyer FG, Liu G, Johnston CC, Christian J, Peacock M. Polymorphism at an Spl binding site of COL1A1 and bone mineral density in premenopausal female twins and elderly fracture patients. Osteoporos Int 1999; 9: 346–350.
Styrkarsdottir U, Gudjonsdottir K, Johannsdottir VD, Jonasson K, Grant SFA, Thors H, et al. The Spl polymorphism in the COLIAI Gene is not associated with BMD or osteoporosis related fractures in the Icelandic population. J Bone Miner Res 2000; 15 (suppl 1): S363.
Heegaard A-M, Jorgensen HL, Vestergaard AW, Hassager C, Ralston SH. Lack of influence of collagen type la Spl binding site polymorphism on the rate of bone loss in a cohort of postmenopausal Danish women followed for 18 years. Calcif Tissue Int 2000; 66: 409–441.
McLellan AR, Jagger C, Spooner R, Sutcliffe R, Harrison J, Shapiro D. Are COL 1 A 1 Spi polymorphisms important determinants of bone mineral density and osteoporosis in postmenopausal women in the UK? J Bone Miner Res 1997; 12: S119.
Liden M, Wilen B, Lunghall S, Melhus H. Polymorphism at the Spl binding site in the collagen type I alpha 1 gene does not predict bone mineral density in postmenopausal women in Sweden. Calcif Tissue Int 1998; 63: 293–295.
Vandevyver C, Philippaerts L, Cassiman J-J, Raus J, Geusens P. Bone mineral density in postmenopausal women is not associated with type I colagen (COL-1A1 and COL-IA!) dimorphisms. J Bone Miner Res 1997; 12: S490.
Hustmyer FG, Liu G, Christian JC, Johnston CC, Peacock M. Is the polymorphism at the Spl binding site in the COL 1 Al gene associated with bone mineral density. J Bone Miner Res 1997; 12 (Suppl): S490.
Jagger C, Swan L, Harrison J, Rowan M, McColl J, Spooner R, Shapiro D, McLellan AR. Evidence that vitamin D receptor genotype, but not COLIA1 genotype may contribute to the heritability of bone mineral density: the Scottish Twin Study. Bone 1998; 23 (Suppl): S372.
Lim S-K, Li SZ, Won YJ, Shin W-Y, Lee HC, Huh KB. Lack of association between a polymorphic Sp1 binding site in collagen type 1 alpha 1 gene and osteoporosis in Korean. J Bone Miner Res 1997; 12 (Suppl): S491.
Nogues X, Garcia-Giral N, Enjuanes A, Grinberg D, Mellibovsky L, Minguez S,et al. Genetic study of bone mass determinants in perimenopausal Spanish women. Bone 1998; 23 (Suppl): S371.
Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H. Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 1996; 11 (3): 306–311.
Sowers MF, Aron D, Burns T, Clark K, Willing M. Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 1997; 12 (Suppl): S 175.
Huang Q, Wang Q, Zhang L, Zhou Q, Lu J. Relationship between bone mineral density and polymorphism of the estrogen receptor gene in Chinese postmenopausal women. Bone 1998; 23 (Suppl): S370.
Nelson DA, Kleerekoper M. The search for the osteoporosis gene. J Clin Endocrinol Metab 1997;82(4):989–990.
Mahonen A, Turunen A-M, Kroger H, Maenpaa PH. Estrogen receptor gene polymorphism is associated with bone mineral density in perimenopausal Finnish women. J Bone Miner Res 1997; 12 (Suppl): S255.
Langdahl BL, Lokke E, Carstens M, Eriksen EF. Polymorphisms in the estrogen receptor gene show different distributions in osteoporotic patients and normal controls. J Bone Miner Res 1997; 12 (Suppl): S255.
Sikic-Klisovic E, Badenhop NE, Skugor M, Klisovic D, Ilich JZ, Landoll JD, et al. Estrogen receptor gene polymorphism differentiates bone mass in adult males more than in females. Bone 1998; 23 (Suppl): S370.
Becherini L, Gennari L, Mansani R, Masi L, Gonneli S, Colli E, et al. Estrogen receptor-a gene polymorphisms and osteoporosis: a large scale study on postmenopausal women. Bone 1998;23 (Suppl):SS269.
Zmuda JM, Cauley JA, Glynn NW, Lee M, Kuller LH, Ferrell RE. A common estrogen receptor gene variant is associated with hip bone density in older men. Bone 1998; 23 (Suppl): S269.
Salmen T, Heikkinen A-M, Mahonen A, Kroger K, Komulainen M, Saarikoski S, et al. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: Effect of hormone replacement therapy. J Bone Miner Res 2000; 15: 315–321.
Jorgensen HL, Heegaard AM, Bayer L, Hansen L, Hassager C. PvuII and Xba7 restriction fragment length polymorphism at the estrogen receptor (ER) locus and its relation to bone mineral density (BMD) and bone loss in postmenopausal Danish women. 1997; 12 (Suppl): S254.
Han KO, Moon EG, Kang YS, Chung HY, Min EH, Han WK. Nonassocation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women. J Clin Endocrinol Metab 1997; 82: 991–995.
Kindmark A, Carling T, Melhus H, Ljunghall S. Estrogen receptors and osteoporosis: Lack of association between disease and polymorphisms at three different loci. Bone 1998; 23 (Suppl): S369.
Vandevyver C, Vanhoof J, Declerck K, Stinissen P, Vandervorst C, Michiels L, et al. Lack of association between estrogen receptor genotypes and bone mineral density, fracture history or muscle strength in elderly women. J Bone Miner Res 1999; 14: 1576–1582.
Mizunuma H, Hosoi T, Okano H, Soda M, Tokizawa T, Kagami I, Miyamoto S, et al. Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre-and postmenopausal women. Bone 1997; 21: 379–383.
Kohlmeier M, Saupe J, Schaefer K, Asmus G. Bone fracture history and prospective bone fracture risk of hemodialysis patients are related to apolipoprotein E genotype. Calcif Tissue Int 1998; 62: 278–281.
Salamone LM, Cauley JA, Zmuda J, Pasagian-Macauley A, Epstein RS, Ferrell RE, et al. Apolipoprotein E gene polymorphism and bone loss: estrogen status modifies the influence of apolipoprotein E on bone loss. J Bone Miner Res 2000; 15: 308–314.
Shiraki M, Shiraki Y, Aoki C, Hosoi T, Inoue S, Kaneki M, Ouchi Y. Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 1997; 12: 1438–1445.
Heikkinen A-M, Kroger H, Niskanen L, Komulainen MH, Ryynanen M, Parviainen M, et al. Does apolipoprotein E genotype relate to BMD and bone markers in postmenopausal women? Maturitas 2000; 34: 33–41.
Murray RE, McGuigan F, Grant SF, Reid DM, Ralston SH. Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone 1997; 21: 89–92.
Takacs I, Koller DL, Peacock M, Christian JC, Evans WE, Hui SL, et al. Sib pair linkage and association studies between bone mineral density and the interleukin-6 gene locus. Bone 2000; 27: 169–173.
Langdahl BL, Knudsen JY, Jensen HK, Gregersen N, Eriksen EF. A sequence variation: 713–8de1C in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 1997; 20 (3): 289–294.
Johnson ML, Gong G, Kimberling W, Recker SM, Kimmell DB, Recker RR. Linkage of a gene causing high bone mass to human chromosome 11 (11g12–13). Am J Hum Genet 1997; 60: 1326–1332.
Recker RR, Davies DK, Recker SM. Characterizing the phenotype in a kindred with autosomal dominant high bone mass. Bone 1998; 23 (Suppl): S274.
Gong Y, Vikkula M, Boon L, Liu J, Beighton P, Ramesar R, et al. Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12–13. Am J Hum Genet 1996; 59 (1): 146–51.
Heaney C, Carmi R, Dushkin H, Sheffield V, Beier DR. Genetic mapping of recessive osteopetrosis to 11g12–13. Am J Hum Genet 1997;61 (Suppl):Al2.
Devoto M, Shimoya K, Caminis J, Ott J, Tenenhouse A, Whyte MP, et al. First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q. Eur J Hum Genet 1998; 6: 151.
Spotila LD, Devota M, Caminis J, Kosich R, Korkko J, Ott J, et al. Suggested linkage of low bone density to chromosome 1p36 is extended to a second cohort of sib pairs. Bone 1998; 23 (Suppl): 5277.
Koller DL, Rodriguez LA, Christian JC, Slemenda CW, Econs MJ, Hui SL, et al. Linkage of a QTL contributing to normal variation in bone mineral density to chromosome 11g12–13. J Bone Miner Res 1998; 13 (12): 1903–1908.
Koller DL, Econs MJ, Morin PA, Christian JC, Hui SL, Parry P, et al. Genome screen for QTLs contributing to normal variation in bone mineral density and osteoporosis. J Clin Endocrinol Metab 2000; 85: 3116–3120.
Niu T, Chen C, Cordell H, et al. A genome-wide scan for loci linked to forearm bone mineral density. Hum Genet 1999; 104: 226–233.
Little RD, Carully JP, Del Mastro RG, Dupuis J, Osbourne M, Folz C, et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 2002; 70: 11–19.
Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001; 107: 513–523.
Deng HW, Xu FH, Conway T, Deng XT, Li JL, Davies KM, et al. Is population bone mineral density variation linked to the marker D11S987 on chromosome 11g12–13? Clin Endocrinol Metab 2001; 86: 3735–3741.
Flint J, Corley R. Do animal models have a place in the genetic analysis of quantitative human beavioural traits? J Mol Med 1996; 74: 515–521.
Miller SC, Bowman BM, Jee WSS. Available animal models of osteopenia-small and large. Bone 1995; 17 (Suppl): 117S - 1235.
Kimmel DB. Animal models for in vivo experimentation in osteoporosis research. In: Marcus R, ed. Osteoporosis. Academic Press, San Diego, CA, 1996, pp. 671–690.
Aerssens J, Boonen S, Lowet G, Dequeker J. Interspecies differences in bone composition, density, and quality: potential implications for in vivo bone research. Endocrinol 1998; 139: 663–670.
Bar-Shira-Maymon B, Coleman R, Cohen A, Steinhagen-Thiessen E, Slibermann M. Age-related loss in lumbar vertebrae of CW-1 female mice: a histomorphometric study. Calcif Tiss Int 1989; 44: 36–45.
Weiss A, Arbell I, Steinhagen-Thiessen E, Silbermann M. Structural changes in aging bone: osteopenia in the proximal femurs of female mice. Bone 1991; 12: 165–172.
Kimmel DB. Quantitative histologic changes in the proximal tibial epiphyseal growth cartilage of aged female rats. Cells Mater 1992; 1 (Suppl): 11–18.
Schapira D, Laton-Miller R, Barzilai D, Silbermann M. The rat as a model for studies of the aging skeleton. Cells Mater 1992; 1 (Suppl): 181–188.
Li XJ, Jee WJS, Ke HZ, Mori S, Akamine T. Age-related changes of cancellous and cortical bone histomorphometry in female Sprague-Dawley rats. Cells Mater 1992; 1 (Suppl): 25–37.
Suzuki HK. Effects of estradiol-17-ß-n-valerate on endosteal ossification and linear growth in the mouse femur. Endocrinology 1958; 60: 743–747.
Edwards MW, Bain SD, Bailey MC, lantry MM, Howard GA. 17-ß-estradiol stimulation of endosteal bone formation in the ovariectomized mouse: an animal model for the evaluation of bone-targeted estrogens. Bone 1992; 13: 29–34.
Donahue LR, Rosen CJ, Beamer WG. Reduced bone density in hypogonadal mice. J Bone Miner Res 1994; 9 (Suppl): S193.
Kalu DN. The ovariectomized rat as a a model of postmenopausal osteopenia. Bone Miner 1991; 15: 175–191.
Wronski TJ. The ovariectomized rat as an animal model for postmenopausal bone loss. Cells Mater 1992; 1 (Suppl): 69–74.
Mosekilde L, Danielsen CC, Knudsen UB. The effect of aging and ovariectomy on the vertebral bone mass and biomechanical properties of mature rats. Bone 1993; 14: 1–6.
Matsushita M, Tsuboyama T, Kasai R, Okumura H, Yamamuro T, Higuchi K, et al. Age-related changes in the senescence-accelerated mouse (SAM). Am J Pathol 1986; 125: 276–283.
Tsuboyama T, Takahashi K, Matsushita M, Okumura H, Yamamuro T, Umezawa M, et al. Decreased endosteal formation during cortical bone modeling in SAM-P/6 mice with a low peak bone mass. Bone Miner 1989; 7: 1–12.
Tsuboyama T, Matsushita M, Okumura H, Yamamuro T, Hanada K, Takeda T. Modification of strain-specific femoral bone density by bone marrow chimerism in mice: a study on the spontaneously osteoporotic mouse (SAM-P/6). Bone 1989; 10: 269–277.
Takahashi K, Tsuboyama T, Matsushita M, Kasai R, Okumura H, Yamamuro T, et al. Modification of strain-specific femoral bone density by bone marrow-derived factors administered neonatally: A study on the spontaneously osteoporotic mouse (SAM-P/6). Bone Miner 1994; 23: 57–64.
Takahashi K, Tsuboyama T, Matsushita M, Kasai R, Okumura H, Yamamuro T, et al. Effective intervention of low peak bone mass and modeling in the spontaneous murine model of senile osteoporosis, SAM-P/6, by calcium supplement and hormone treatment. Bone 1994; 15: 209–215.
Tsuboyama T, Takahashi K, Yamamuro T, Hosokawa M, Takeda T. Cross-mating study on bone mass in the spontaneously osteoporotic mouse (SAM-P/6). Bone Miner 1993; 23: 57–64.
Jilka RL, Weinstein RS, Takahashi K, Parfitt MA, Manolagos SC. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest 1996; 97: 1732–1740.
Weinstein RS, Jilka RL, Parfitt AM, Manolagos SC. The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage. Endocrinol 1997; 138: 4013–4021.
Schnitzler CM, Ripamonti U, Mesquita JM. Histomorphometry of iliac crest trabecular bone in adult male baboons in captivity. Calcif Tiss Int 1993; 52: 447–454.
Jayo MJ, Jerome CP, Lees CJ, Rankin SE, Weaver DS. Bone mass in female cynomolgus macaques: a cross-sectional and longitudinal study by age. Calcif Tiss Int 1994; 54: 231–236.
Pope NS, Gould KG, Anderson DC, Mann DR. Effects of age and sex on bone density in the rhesus monkey. Bone 1989; 10: 109–112.
Jayo MJ, Rankin SE, Weaver DS, Carlson CS, Clarkson TB. Accuracy and precision of lumbar bone mineral content by DXA in live female monkeys. Calcif Tiss Int 1991; 49: 438–440.
Jerome C, Kimmel DB, McAlister JA, Weaver DS. Effects of ovariectomy on iliac trabecular bone in baboons (Papio anubis). Calcif Tiss Int 1986; 39: 206–208.
Miller C, Weaver D. Bone loss in ovariectomized monkeys. Calcif Tiss Int 1986; 38: 62–65.
Lundon K, Dumitriu M, Grynpas M. The long-term effect of ovariectomy on the quality and quantitiy of cancellous bone in young macaques. Bone Miner 1994; 24: 135–149.
Aufdemorte TB, Fox WC, Miller D, Buffum K, Holt GR, Carey KD. A non-human primate model for the study of osteoporosis and oral bone loss. Bone 1993; 14: 581–586.
Grynpas MD, Huckell CB, Reichs KJ, Derousseau CJ, Greenwood C, Kessler MJ. Effect of age and osteoarthritis on bone mineral in rhesus monkey vertebrae. J Bone Miner Res 1993; 8: 909–917.
Carlson CS, Loeser RF, Jayo MJ, Weaver DS, Adams MR, Jerome CP. Osteoarthritis in cynomolgus macaques: a primate model of naturally occuring disease. J Orthop Res 1994; 12: 331–339.
Kimmel DB, Lane NE, Kammerer CM, Stegman MR, Rice KS, Recker RR. Spinal pathology in adult baboons. J Bone Miner Res 1993; 8 (Suppl): S279.
Hughes KP, Kimmel DB, Kammerer CM, Stegman MR, Rice KS, Recker RR. Vertebral morphometry in adult female baboons. J Bone Miner Res 1994; 9 (Suppl): S209.
Orwoll ES, Oviatt SK, Mann T. The impact of osteophytic and vascular calcifications on vertebral mineral density measurements in men. J Clin Endocrinol Metab 1990; 70: 1202–1207.
Paigen K. A miracle enough: the power of mice. Nature Med 1995; 1: 215–220.
Frankel WN. Taking stock of complex trait genetics in mice. Trends Genet 1995; 11: 471–477.
Malakoff D. The rise of the mouse, biomedicine’s model mammal. Science 2000; 288: 248–253.
Kaye M, Kusy RP. Genetic lineage, bone mass, and physical activity. Bone 1995; 17: 131–135.
Beamer WG, Donahue LR, Rosen CJ, Baylink DJ. Genetic variability in adult bone density among inbred strains of mice. Bone 1996; 18: 397–403.
Rosen CJ, Dimai HP, Vereault D, Donahue LR, Beamer WG, Farley J, et al. Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. Bone 1997; 21: 217–223.
Green MC. Catalogue of mutant genes and polymorphic loci. In: Searle M, ed. Genetic Variants and Strains of the Laboratory Mouse. Oxford University Press, Oxford, UK, 1989, pp. 12–403.
Green MC. Further morphological effects of the short-ear gene in the house mouse. J Morph 1951; 88: 1–2.
Green MC. Effects of the short-ear gene in the mouse on cartilage formation in healing bone fractures. J Exp Zool 1958; 137: 75–88.
Mikiç B, van der Meulen MC, Kingsley DM, Carter DR. Long bone geometry and strength in adult BMP-5 deficient mice. Bone 1995; 16 (4): 445–454.
Kingsley DM, Bland AE, Grubber JM, Marker PC, Russell LB, Copeland NG, et al. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF beta superfamily. Cell 1992; 71 (3): 399–410.
Lohler J, Timpl R, Jaenisch R. Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death. Cell 1984; 38: 597–607.
Bonadio J, Saunders TL, Tsai E, Goldstein SA, Morris-Wiman J, Brinkley L, et al. A transgenic mouse model of osteogenesis imperfecta type I. Proc Natl Acad Sci USA 1990; 87: 7145–7149.
Khillan JS, Olsen AS, Kontsaari S, Sokolov B, Prockop DJ. Transgenic mice that express a mini-gene version of the human gene for type I procollagen (COLIA!) develop a phenotype resembling a lethal form of osteogenesis imperfecta. J Biol Chem 1991; 266: 23373–23379.
Pereira RF, Hume EL, Halford KW, Prockop DJ. Bone fragility in transgenic mice expressing a mutated gene for type I procollagen (COL1A1) parallels the age-dependent phenotype of human osteogenesis imperfecta. J Bone Miner Res 1995; 10: 1837–1843.
Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990; 345: 442–444.
Soriano P, Montgomery C, Geske R, Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991; 64: 693–702.
Wang Z, Ovitt C, Grigoriadis AE, Mohle-Steinlein U, Ruther U, Wagner EF. Bone and hematopoietic defects in mice lacking c-fos. Nature 1992; 360: 741–745.
Hodgkinson CA, Moore KJ, Nakayama A, Steingrimsson E, Copeland NG, Jenkins NA, et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 1993; 74: 395–404.
Klein RF, Mitchell SR, Phillips TJ, Belknap JK, Orwoll ES. Quantitative trait loci affecting peak bone mineral density in mice. J Bone Miner Res 1998; 13: 1648–1656.
Taylor BA. Recombinant inbred strains: Use in gene mapping. In: Morse HC, ed. Origins of Inbred Mice. Academic Press, New York, 1978, pp. 423–438.
Beamer WG, Shultz KL, Churchill GA, Frankel WN, Baylink DJ, Rosen CJ, et al. Quantitative trait loci for bone density in C57BL/6J and CAST/EiJ inbred mice. Mamm Genome 1999; 10: 1043–1049.
Benes H, Weinstein RS, Zheng W, Thaden JJ, Jilka RL, Manolagos SC, et al. Chromosomal mapping of osteopenia-associated quantitative trait loci using closely related mouse strains. J Bone Miner Res 2000; 15: 626–633.
Shimizu M, Higuchi K, Bennett B, Xia C, Tsuboyama T, Kasai S, et al. Identification of peak bone mass QTL in a spontaneously osteoporotic mouse strain. Mamm Genome 1999; 10 (2): 81–87.
Darvasi A. Experimental strategies for the genetic dissection of complex traits in animal models. Nat Genet 1998; 18: 19–24.
Moreadith RW, Radford NB. Gene targeting in embryonic stem cells: the new physiology and metabolism. J Mol Med 1997; 75: 208–216.
Porcu S, Kitamura M, Witkowska E, Zhang Z, Mutero A, Lin C, et al. The human beta globin locus introduced by YAC transfer exhibits a specific and reproducible pattern of developmental regulation in transgenic mice. Blood 1997; 90: 4602–4609.
Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990; 234: 541–544.
Bailey DW. Recombinant inbred strains and bilineal congenic strains. In: Foster HL, Small JD, Fox JG, eds. The Mouse in Biomedical Research, Vol. I: History, Genetics, and Wild Mice. Academic Press, New York, 1981, pp. 223–239.
Dudek BC, Underwood K. Selective breeding, congenic strains, and other classical genetic approaches to the analysis of alcohol-related polygenic pleotropisms. Behav Genet 1993; 23: 179–190.
Flaherty L. Congenic strains. In: Foster HL, Small JD, Fox JG, eds. The Mouse in Biomedical Research, Vol. I: History, Genetics, and Wild Mice. Academic Press, New York, 1981, pp. 215–222.
Lisitsyn NA, Segre JA, Kusumi K, Lisitsyn NM, Nadeau JH, Frankel WN, et al. Direct isolation of polymorphic markers linked to a trait by genetically directed representational difference analysis. Nature Genet 1994; 6: 57–63.
Eddy DM. Common screening tests. In: Eddy DM, ed. Common Screening Tests. American College of Physicians, Philadelphia, PA, 1991.
Johnston CCJ, Cummings SR, Dawson-Hughes B, Lindsay R, Melton U, Slemenda CW. Physician’ s Guide to Prevention and Treatment of Osteoporosis. National Osteoporosis Foundation, Washington, DC, 1998, pp. 1–30.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Klein, R.F., Foroud, T. (2003). Human and Animal Studies of the Genetics of Osteoporosis. In: Orwoll, E.S., Bliziotes, M. (eds) Osteoporosis. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-278-4_1
Download citation
DOI: https://doi.org/10.1007/978-1-59259-278-4_1
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-260-5
Online ISBN: 978-1-59259-278-4
eBook Packages: Springer Book Archive